Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims to add 1,000 new staffers over 5 years
Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims [...]
Polyphor sharpens ax on staff, shutters failed breast cancer test
Polyphor sharpens ax on staff, shutters failed breast cancer test [...]
GSK sells off part of its U.K. R&D site to rake in $554M and boost biotech ops
GSK sells off part of its U.K. R&D site to [...]
ACB hires Liu from Eureka Therapeutics to lead push into clinic
ACB hires Liu from Eureka Therapeutics to lead push into [...]
Ribon, backed by biopharma majors, raises $65M to take PARP7 inhibitor deeper into the clinic
Ribon, backed by biopharma majors, raises $65M to take PARP7 [...]
Eli Lilly’s $1B buyout bet for Protomer brings the ‘next frontier’ in smart insulin tech under the Big Pharma’s wing
Eli Lilly’s $1B buyout bet for Protomer brings the ‘next [...]
Ionis pays Bicycle $45M to expand oligonucleotide delivery toolkit
Ionis pays Bicycle $45M to expand oligonucleotide delivery toolkit ntaylor [...]
Nimbus raises $105M for multifront TYK2 clinical trial program
Nimbus raises $105M for multifront TYK2 clinical trial program ntaylor [...]
Biogen taps Chinese biotech InnoCare in $125M midstage MS drug pact
Biogen taps Chinese biotech InnoCare in $125M midstage MS drug [...]
Penn team uses CRISPR to edit out genetic disease before and after birth in mice
Penn team uses CRISPR to edit out genetic disease before [...]